This week: high science that affect future treatments; breakthrough infections in our patients, and what's up with that; and soon your radiologist is going to be replaced by AI. This and more in our review of the news and journal articles from the past week.

The FDA has again extended its decision on whether the manufacturers of vaping products can market their e-cigarettes in the United States. Previously, the manufacturers (Juul, Vuse and Blu) were given until September 2020 to submit data to the FDA on the use and safety of these vaping products, but were given a one year grace period without FDA enforcement, while the agency reviewed their applications.

A retrospective study of systemic sclerosis patients shows that acute hospitalization and mortality were not uncommon and were often linked to SSc-related lung disease. Record review of 95 SSc patients from a single-centre cohort seen between 2010 and 2020 found that over half (53 patients) required acute hospitalization, with a total of 164 admissions. The most frequent causes for hospitalization: